IL7R and precursor B-cell acute lymphoblastic leukemia: Adding to this complexity, recent findings have shown elevated expression of the IL7Rα chain (CD127)—a key subunit of IL7R—in B-ALL patients harboring TP53 mutations and CRLF2 rearrangements [11], further highlighting the potential relevance of IL7R signaling in high-risk disease and CNS involvement.